Zhou Huanfen, Xu Quangang, Zhao Shuo, Wang Wei, Wang Junqing, Chen Zhiye, Lin Dahe, Li Xiaoming, Peng Chunxia, Ai Nanping, Wei Shihui
Department of Ophthalmology, Chinese PLA General Hospital, Beijing, China.
Department of Ophthalmology, The first Affiliated Hospital of Chinese PLA General Hospital, Beijing, China.
Br J Ophthalmol. 2017 Dec;101(12):1720-1724. doi: 10.1136/bjophthalmol-2017-310157. Epub 2017 Apr 12.
To evaluate the clinical features and prognosis of atypical optic neuritis (ON) with seronegative aquaporin-4 (AQP4) antibody in Chinese patients.
All patients with first or relapsing ON were recruited from the Neuro-ophthalmology Department of the Chinese People's Liberation Army General Hospital from January 2013 to December 2014 and assigned to one of three groups based on diagnosis: atypical ON, typical ON and neuromyelitis optica spectrum disorder (NMOSD)-ON.
A total of 173 patients were included in the cohort. Fifty patients (28.9%) were AQP4-Ab-positive and diagnosed with NMOSD-ON. Of 123 patients with seronegative AQP4-Ab, 37 (30.1%) patients had atypical ON, with male predominance (25, 67.6%). The atypical ON group (compared with the typical ON and NMOSD-ON groups) had a significantly lower female:male ratio (1:2.1 vs 1.8:1 and 9:1, respectively, p=0.001 and p<0.001), an older mean age of onset (44.8, 13-71 years vs 36.9, 13-73 years and 36.2, 13-66 years, p=0.003 and p=0.004), a lower rate of good (≥0.5) visual recovery (6.7% vs 79.8% and 30.9%, p<0.001 and p<0.001) and (compared with the NMOSD-ON group) a lower recurrence rate during a 2-year follow-up (29.3% vs 60%, p=0.009). However, none developed to multiple sclerosis or neuromyelitis optica in the atypical ON group.
Atypical ON with seronegative AQP4-Ab had unique clinical features in this Chinese cohort, including male predominance, an older age of onset, worse visual acuity recovery and resistance to corticosteroid therapy. This condition may be a distinct nosological entity with an unusual clinical and therapeutic profile.
评估中国患者中血清阴性水通道蛋白4(AQP4)抗体的非典型视神经炎(ON)的临床特征及预后。
选取2013年1月至2014年12月在中国人民解放军总医院神经眼科就诊的所有初发或复发ON患者,并根据诊断结果分为三组:非典型ON组、典型ON组和视神经脊髓炎谱系障碍(NMOSD)-ON组。
该队列共纳入173例患者。50例(28.9%)患者AQP4抗体阳性,诊断为NMOSD-ON。在123例血清阴性AQP4抗体患者中,37例(30.1%)为非典型ON,以男性为主(25例,占67.6%)。非典型ON组(与典型ON组和NMOSD-ON组相比)的女性与男性比例显著更低(分别为1:2.1、1.8:l和9:1,p=0.001和p<0.001),平均发病年龄更大(44.8岁,13 - 71岁,而典型ON组为36.9岁,13 - 73岁;NMOSD-ON组为36.2岁,13 - 66岁,p=0.003和p=0.004),视力恢复良好(≥0.5)的比例更低(6.7%,而典型ON组为79.8%,NMOSD-ON组为30.9%,p<0.001和p<0.001),且(与NMOSD-ON组相比)在2年随访期间复发率更低(29.3%比60%,p=0.009)。然而,非典型ON组中无患者发展为多发性硬化或视神经脊髓炎。
在该中国队列中,血清阴性AQP4抗体的非典型ON具有独特的临床特征,包括男性为主、发病年龄较大、视力恢复较差以及对皮质类固醇治疗耐药。这种情况可能是一种具有不寻常临床和治疗特征的独特病种。